Clinical Trial Update: CAPRIVI: Community Acquired Pneumonia: Treatment With Avelox® in Hospitalized Patients

View source ↗

Summary

Completed trial evaluating the effectiveness of Avelox (moxifloxacin) for treatment of community-acquired pneumonia in hospitalized patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia

Drugs mentioned

• Avelox (moxifloxacin)

Snippet

Sponsor: Bayer | Conditions: Pneumonia | Status: COMPLETED